bosentan anhydrous has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prakash, A; Singh, M | 1 |
| Bonetti, PO; Elesber, AA; Lerman, A; Lerman, LO; Woodrum, JE; Younkin, SG; Zhu, XY | 1 |
2 other study(ies) available for bosentan anhydrous and Alzheimer Disease
| Article | Year |
|---|---|
Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Bosentan; Brain; Dementia; Dementia, Vascular; Endothelins; Endothelium, Vascular; Hyperhomocysteinemia; Lipid Peroxidation; Male; Maze Learning; Memory; Methionine; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides | 2017 |
Bosentan preserves endothelial function in mice overexpressing APP.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Female; Mice; Mice, Inbred C57BL; Mice, Transgenic; Sulfonamides; Vasodilation | 2006 |